Europe Acute Pancreatitis Market Forecast to 2030

Europe Acute Pancreatitis Market Forecast to 2030

Europe Acute Pancreatitis Market Forecast to 2030 – Regional Analysis – by Offerings (Medications, Diagnosis, and Others), Causes (Gallstones, Alcoholism, Genetic Disorders, Infection, and Others), and End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Others)

Send Enquiry
Item ID: BMIRE00029223 Category: Tag:

$2,485 – $3,885

Description

The Europe acute pancreatitis market was valued at US$ 1,492.10 million in 2022 and is expected to reach US$ 2,260.69 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Rising Incidence of Diabetes Following Acute Pancreatitis Fuels the Europe Acute Pancreatitis Market

The pancreas produces insulin, a hormone that regulates blood sugar levels. Pancreatitis can harm insulin-producing cells of pancreas, which causes diabetes in patients suffering from acute pancreatitis. People suffering from acute pancreatitis are at a twofold greater risk of diabetes as compared to the general population. Diabetes sequelae are observed across the spectrum of severity in acute pancreatitis and can accompany other clinical complications.

As per the European Review for Medical and Pharmacological Sciences, published in 2022, the prevalence of pancreatogenic diabetes is 5–10% in the Western diabetic population, and chronic pancreatitis is responsible for 20% of cases while acute pancreatitis causes 80% of cases. According to an article published in the National Library of Medicine in 2021, ~23% of acute pancreatitis patients are likely to develop diabetes within three years of discharge. Further, an article published in the Journal of Gastroenterology in 2020 states that following acute pancreatitis, ~3%, 7%, 9%, and 11% of patients develop diabetes at 6, 12, 18, and 24 months of discharge, respectively. According to an article published in the MDPI, in 2023, ~40% of patients with acute pancreatitis are affected by prediabetes and diabetes and are at a higher risk of death and readmission to hospitals than patients with type 2 diabetes. Further, ~ 60.2% of adult patients developed diabetes after acute pancreatitis, and 9% of children after acute recurrent pancreatitis or with chronic pancreatitis, and this risk increases as they age into adulthood. Researchers have noted higher diabetes incidence (~39%) after severe acute pancreatitis than mild acute pancreatitis (14%) in a meta-analysis comparing severe and mild acute pancreatitis. Thus, the increasing incidence of diabetes in patients suffering or recovering from acute pancreatitis contributes to the growth of the Europe acute pancreatitis market.

Europe Acute Pancreatitis Market Overview

The Europe acute pancreatitis market is segmented into Germany, the UK, France, Italy, Spain, Nordic Countries, The Netherlands, and the Rest of Europe. Countries such as Germany and the UK are expected to be the largest contributors to the market in this region. The rising prevalence of acute pancreatitis and increase in alcohol consumption are the major factors driving the market growth in Europe. According to the Federal Statistical Office, health expenditure in Germany amounted to US$ 460.03 billion in 2019. It is an attractive market for companies offering therapeutic products for acute pancreatitis due to its innovative approach toward healthcare. Medical device manufacturers in Germany can also seek government funding for a variety of research projects and receive grants from the Kreditanstalt für Wiederaufbau (KfW). The increasing focus of manufacturers on new product development and strategic collaborations to develop advanced diagnostic devices such as acute pancreatitis is expected to further propel the market growth in the coming years.

Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)

Europe Acute Pancreatitis Market Segmentation

The Europe acute pancreatitis market is segmented offerings, causes, end user, and country.

Based on offerings, the Europe acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held the largest market share in 2022.

Based on method, the Europe acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held the largest market share in 2022.

Based on end user, the Europe acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe acute pancreatitis market is segmented into the U.K., Germany, France, Italy, Spain, the Nordic Countries, the Netherlands, and the Rest of Europe. Germany dominated the Europe acute pancreatitis market share in 2022.

Abbott Laboratories, Actim Oy, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare are some of the leading companies operating in the Europe acute pancreatitis market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 5.3% CAGR, the Europe Acute Pancreatitis Market is speculated to be worth US$ 2,260.69 million by 2030, says the research team

According to the research team’ research, the Europe acute pancreatitis market was valued at US$ 1,492.10 million in 2022 and is expected to reach US$ 2,260.69 million by 2030, registering a CAGR of 5.3% from 2022 to 2030. Rise in pancreatic cancer cases due to acute pancreatitis, rising incidence of diabetes following acute pancreatitis, and upsurge in number of R&D activities and awareness programs on acute pancreatitis are among the critical factors attributed to the Europe acute pancreatitis market expansion.

Extensive research studies are being conducted globally to investigate the etiology, progress, and treatment of acute pancreatitis. The National Pancreas Foundation (NPF) provides multiple research grants worth ~US$ 50,000 per project. To date, the NPF has provided more than US$ 5 million for 133 ground-breaking research projects. A grant is awarded for a period of a year to diagnose and/or treat pancreatitis, pancreatic cancer, or pediatric pancreatitis. Further, several ongoing international efforts are being made to define the epidemiology and pathophysiology of acute pancreatitis. Thus, R&D activities and awareness programs on acute pancreatitis for the development of effective therapies (through direct and indirect means) are expected to be highly fruitful for companies in the Europe acute pancreatitis market.

On the contrary, side effects of pancreatitis and pancreatic cancer treatments hampers on the growth of Europe acute pancreatitis market.

Based on offerings, the Europe acute pancreatitis market is segmented into medications, diagnosis, and others. The diagnosis segment held 56.3% share of Europe acute pancreatitis market in 2022, amassing US$ 840.53 million. It is projected to garner US$ 1,268.13 million by 2030 to expand at 5.3% CAGR during 2022–2030.

Based on method, the Europe acute pancreatitis market is segmented into gallstones, alcoholism, genetic disorders, infection, and others. The gallstones segment held 47.4% share of Europe acute pancreatitis market in 2022, amassing US$ 707.64 million. It is projected to garner US$ 1,102.55 million by 2030 to expand at 5.7% CAGR during 2022–2030.

Based on end user, the Europe acute pancreatitis market is divided into hospitals, diagnostic laboratories, ambulatory surgical centres, and others. The hospitals segment held 74.8% share of Europe acute pancreatitis market in 2022, amassing US$ 1,115.70 million. It is projected to garner US$ 1,679.68 million by 2030 to expand at 5.2% CAGR during 2022–2030.

Based on country, the Europe acute pancreatitis market has been categorized into the U.K., Germany, France, Italy, Spain, the Nordic Countries, the Netherlands, and the Rest of Europe. Our regional analysis states that Germany captured 29.5% share of Europe acute pancreatitis market in 2022. It was assessed at US$ 439.42 million in 2022 and is likely to hit US$ 645.88 million by 2030, exhibiting a CAGR of 4.9% during 2022–2030.

Key players operating in the Europe acute pancreatitis market are Abbott Laboratories, Actim Oy, Baxter International Inc, Boston Scientific Corp, Dynavax Technologies Corp, Fresenius Kabi AG, GE HealthCare Technologies Inc, Koninklijke Philips NV, Medtronic Plc, and Samsung Healthcare, among others.

In Oct 2021; Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, introduced the V8, a new high-end ultrasound system that provides enhanced image quality, usability and convenience for all medical professionals.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe acute pancreatitis market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe acute pancreatitis market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Europe Acute Pancreatitis Market, by Country (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Acute Pancreatitis Market Landscape
4.1 Overview
5. Europe Acute Pancreatitis Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Pancreatic Cancer Cases Due to Acute Pancreatitis
5.1.2 Rising Incidence of Diabetes Following Acute Pancreatitis
5.2 Key Market Restraints
5.2.1 Side Effects of Pancreatitis and Pancreatic Cancer Treatments
5.3 Key Market Opportunities
5.3.1 Upsurge in Number of R&D Activities and Awareness Programs on Acute Pancreatitis
5.4 Future Trends
5.4.1 Advancements in Specific Acute Pancreatitis Treatments
5.5 Impact Analysis:
6. Acute Pancreatitis Market – Europe Market Analysis
6.1 Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
7. Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Offerings
7.1 Overview
7.2 Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
7.3 Medications
7.3.1 Overview
7.3.2 Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Europe Acute Pancreatitis Market, by Medications, 2020–2030 (US$ Million)
7.4 Diagnosis
7.4.1 Overview
7.4.2 Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Europe Acute Pancreatitis Market, by Diagnosis, 2020–2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by Causes
8.1 Overview
8.2 Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
8.3 Gallstones
8.3.1 Overview
8.3.2 Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alcoholism
8.4.1 Overview
8.4.2 Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Genetic Disorders
8.5.1 Overview
8.5.2 Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Infections
8.6.1 Overview
8.6.2 Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Diagnostic Laboratories
9.4.1 Overview
9.4.2 Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Acute Pancreatitis Market – Country Analysis
10.1 Overview
10.1.1.1 Europe Acute Pancreatitis Market, by Country
10.1.1.2 UK
10.1.1.2.1 Overview
10.1.1.2.2 UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.3 UK: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.1 UK: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.2.3.2 UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.2.4 UK: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.2.5 UK: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.3 Germany
10.1.1.3.1 Overview
10.1.1.3.2 Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.3 Germany: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.1 Germany: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.3.3.2 Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.3.4 Germany: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.3.5 Germany: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.4 France
10.1.1.4.1 Overview
10.1.1.4.2 France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.3 France: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.1 France: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.4.3.2 France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.4.4 France: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.4.5 France: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.5 Italy
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.3 Italy: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.5.3.1 Italy: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.5.3.2 Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.5.4 Italy: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.5.5 Italy: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.6 Spain
10.1.1.6.1 Overview
10.1.1.6.2 Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.3 Spain: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.6.3.1 Spain: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.6.3.2 Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.6.4 Spain: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.6.5 Spain: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.7 Nordic Region
10.1.1.7.1 Overview
10.1.1.7.2 Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.7.3 Nordic Region: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.7.3.1 Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.7.3.2 Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.7.4 Nordic Region: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.7.5 Nordic Region: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.8 Netherlands
10.1.1.8.1 Overview
10.1.1.8.2 Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.8.3 Netherlands: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.8.3.1 Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.8.3.2 Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.8.4 Netherlands: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.8.5 Netherlands: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
10.1.1.9 Rest of Europe
10.1.1.9.1 Overview
10.1.1.9.2 Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.9.3 Rest of Europe: Europe Acute Pancreatitis Market, by Offerings, 2020–2030 (US$ Million)
10.1.1.9.3.1 Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings, 2020–2030 (US$ Million)
10.1.1.9.3.2 Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings, 2020–2030 (US$ Million)
10.1.1.9.4 Rest of Europe: Europe Acute Pancreatitis Market, by Causes, 2020–2030 (US$ Million)
10.1.1.9.5 Rest of Europe: Europe Acute Pancreatitis Market, by End User, 2020–2030 (US$ Million)
11. Europe Acute Pancreatitis Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Europe Acute Pancreatitis Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 GE HealthCare Technologies Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Samsung Healthcare
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Baxter International Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dynavax Technologies Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Actim Oy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medtronic Plc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Boston Scientific Corp
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Fresenius Kabi AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Acute Pancreatitis Market Segmentation
Table 2. Europe Acute Pancreatitis Market, by Medications – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Acute Pancreatitis Market, by Diagnosis – Revenue and Forecast to 2030 (US$ Million)
Table 4. UK: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Germany: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 10. Germany: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 11. Germany: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 12. Germany: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 14. France: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 15. France: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 16. France: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 17. France: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 18. France: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 19. Italy: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 20. Italy: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 21. Italy: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 22. Italy: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 23. Italy: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 24. Spain: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 25. Spain: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 26. Spain: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 27. Spain: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 28. Spain: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. Nordic Region: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 30. Nordic Region: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 31. Nordic Region: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 32. Nordic Region: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 33. Nordic Region: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 34. Netherlands: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 35. Netherlands: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 36. Netherlands: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 37. Netherlands: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 38. Netherlands: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 39. Rest of Europe: Europe Acute Pancreatitis Market, by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 40. Rest of Europe: Europe Acute Pancreatitis Market, For Medications by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 41. Rest of Europe: Europe Acute Pancreatitis Market, For Diagnosis by Offerings – Revenue and Forecast to 2030 (US$ Million)
Table 42. Rest of Europe: Europe Acute Pancreatitis Market, by Causes – Revenue and Forecast to 2030 (US$ Million)
Table 43. Rest of Europe: Europe Acute Pancreatitis Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 44. Recent Inorganic Growth Strategies in the Europe Acute Pancreatitis Market
Table 45. Recent Organic Growth Strategies in the Europe Acute Pancreatitis Market
Table 46. Glossary of Terms, Europe Acute Pancreatitis Market

LIST OF FIGURES

Figure 1. Europe Acute Pancreatitis Market Segmentation, By Country
Figure 2. Europe Acute Pancreatitis Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acute Pancreatitis Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Acute Pancreatitis Market Revenue Share, by Offerings, 2022 & 2030 (%)
Figure 6. Medications: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Diagnosis: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Acute Pancreatitis Market Revenue Share, by Causes 2022 & 2030 (%)
Figure 10. Gallstones: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Alcoholism: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Genetic Disorders: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Infections: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Acute Pancreatitis Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 16. Hospitals: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Diagnostic Laboratories: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Ambulatory Surgical Centers: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Acute Pancreatitis Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acute Pancreatitis Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 21. Europe Acute Pancreatitis Market, By Key Countries, 2022 and 2030 (%)
Figure 22. UK: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 23. Germany: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. France: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Italy: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Spain: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Nordic Region: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Netherlands: Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Europe Acute Pancreatitis Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in the Europe Acute Pancreatitis Market

The List of Companies – Europe Acute Pancreatitis Market
o Abbott Laboratories
o Actim Oy
o Baxter International Inc
o Boston Scientific Corp
o Dynavax Technologies Corp
o Fresenius Kabi AG
o GE HealthCare Technologies Inc
o Koninklijke Philips NV
o Medtronic Plc
o Samsung Healthcare

Reviews

There are no reviews yet.

Be the first to review “Europe Acute Pancreatitis Market Forecast to 2030”